Active immunization against alpha-synuclein ameliorates the degenerative pathology and prevents demyelination in a model of multiple system atrophy

Overview of attention for article published in Molecular Neurodegeneration, March 2015

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (94th percentile)
High Attention Score compared to outputs of the same age and source (99th percentile)

Mentioned by

news: 3 news outlets

patent: 4 patents

Citations

dimensions_citation: 131 Dimensions

Readers on

mendeley: 113 Mendeley

Summary News Patents Dimensions citations

So far, Altmetric has seen 4 patents that reference this research output.

A CONJUGATE CONSISTING OF OR COMPRISING AT LEAST A ß-GLUCAN OR A MANNAN

Application WO-2023161527-A1

World Intellectual Property Organisation (WIPO)

Method for vaccination against a self-antigen in a human patient

Grant AU-2016348610-B2

Australia

Antibodies to alpha-synuclein and uses thereof

Grant US-11560424-B2

United States of America

METHOD FOR VACCINATION AGAINST A SELF-ANTIGEN IN A HUMAN PATIENT

Application WO-2017076873-A1

World Intellectual Property Organisation (WIPO)

This page shows the most recent patents that mention this research output.

Click here to find out how to access more activity.